303303
Antidepressivos e ansiolíticos em doentes cardíacos
61. Sayal KS, Duncan‑McConnell DA, McConnell HW, et al. Psychotropic interactions with war-
farin. Acta Psychiatr Scand. 2000; 102:250‑5
62. Nadkarni A, Oldham MA, Howard M, et al. Drug‑drug Interactions between warfarin and
psychotropics: updated review of the literature. Pharmacotherapy. 2012; 32:932‑42.
63. Duncan D, Sayal K, McConnell H, et al. Antidepressant interactions with warfarin. Int Clin
Psychopharmacol. 1998; 13: 87‑94.
64. Brosen K, Naranjo CA. Review of pharmacokinetic and pharmacodynamic interaction stu-
dies with citalopram. Eur Neuropsychopharmacol. 2001; 11: 275‑83.
65. Apseloff G, Wilner KD, Gerber N, et al. Effect of sertraline on protein binding of warfarin.
Clin Pharmacokinet. 1997;32: 37‑42.
66. Dent LA, Orrock MW. Warfarin‑fluoxetine and diazepam‑fluoxetine interaction. Pharmaco-
therapy. 1997; 17: 170‑2.
67. Woolfrey S, Gammack NS, Dewar MS, et al. Fluoxetine‑warfarin interaction. BMJ. 1993;
24:241.
68. Ciraulo DA, Shader RI. Fluoxetine drug‑drug interactions. II. J Clin Psychopharmacol. 1990;
10:213‑217.
69. Benfield P, Ward A. Fluvoxamine.A review of its pharmacodynamic and pharmacokinetic
properties and therapeutic efficacy in depressive illness. Drugs. 1986; 32:313‑34.
70. Bannister SJ, Houser VP, Hulse JD, et al. Evaluation of the potential interactions of paroxetine
with diazepam, cimetidine, warfarin, and digoxin. Acta Psychiatr Scand. 1989; 350:102‑6.
71. Askizazi C. SSRI treatment of depression with comorbid cardiac disease. Am J Psychiatry.
1996; 153:135‑6.
72. Sansone RA, Sansone LA. Warfarin and antidepressants: happiness without hemorrhaging.
Psychiatry (Edgemont). 2009; 6:24‑9. 44:495‑8.
73. Monastero R, Camarda R, Camarda C. Potential drug‑drug interaction between duloxetine
and acenocoumarol in a patient with Alzheimer’s disease. Clin Ther. 2007; 29:2706‑9.
74. Knadler MP, Lobo E, Chappell J, et al. Duloxetine: clinical pharmacokinetics and drug interac-
tions. Clin Pharmacokinet. 2011; 50:281‑94.
75. Norton J, Quarles E. Mirtazapine‑induced warfarin toxicity. Prim Psychiatry. 2002; 9:30‑1.
76. Bavle AD, Phatak AS. Brupropion‑warfarin combination: a serious complication. Indian J
Psychol Med. 2013; 35:311‑3.
77. Small NL, Giamonna KA. Interaction between warfarin and trazodone. Ann Pharmacother.
2000; 34:734‑6.
78. Jalili M, Dehpour AR. Extremely prolonged INR associated with warfarin in combination with
both trazodone and omega‑3 fatty acids. Arch Med Res. 2007; 38:901‑4.
